Cellis Joins Johnson&Johnson’s JLABS EMEA as a Virtual Member Company

We are thrilled to inform that as of April 2025, Cellis has joined Johnson & Johnson’s global incubator network, JLABS EMEA, as a virtual Member Company. JLABS is the largest global network of open innovation ecosystems, enabling and empowering emerging companies with the knowledge, experience, partnerships, and venture connections across a broad healthcare spectrum including pharmaceutical and medical technology sectors.